Skip to main content

Advertisement

Table 3 Comparison of non-MP patients with MP cases

From: Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis

  non-MP (n = 42) MP (n = 10) P value
Age (year) 58.2 ± 14.8 66.1 ± 9.1 .1113a
58.5 (16–86) 67.5 (49–77)
Sex (male/female) 11/31 5/5 .2509b
BMI (kg/m2) 22.5 ± 3.8 23.0 ± 2.3 .7024a
22.5 (16.0–31.4) 22.8 (19.5–27.7)
DM (yes/no) 5/37 3/7 .1710b
HT (yes/no) 14/28 6/4 .1562b
LDL-c (yes/no) 19/23 7/3 .2913b
TG (yes/no) 8/34 4/6 .2125b
Liver disease (yes/no) 0/42 1/9 .1923b
Herbal medicine treatment    
 Ambulatory visit (years) 6.8 ± 4.3 13.9 ± 3.0 .0001c
6.3 (1.5–17.9) 15.1 (6.5–16.3)
 GF administration period (years) 4.2 ± 3.7 11.1 ± 3.5 .0001c
3.1 (0.2–14.8) 12.1 (1.5–15.9)
 Cumulative dosage of GF (g) 1319.7 ± 1077.7 8239.1 ± 3817.4 < .0001c
997.5 (54.0–4542.0) 6539.0 (5379.0–15792.0)
  1. Data are expressed as mean ± S.D. and median (minimum - maximum)
  2. MP mesenteric phlebosclerosis, BMI body mass index, DM diabetes mellitus, HT hypertension, LDL-c elevated low-density lipoprotein cholesterol, TG elevated triglyceride, GF gardenia fruit
  3. aComparison between non-MP group and MP group by Student’s t test
  4. bComparison between non-MP group and MP group by Fisher’s exact test
  5. cComparison between non-MP group and MP group by Mann-Whitney U-test